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ABSTRACT 
 
Fiber Optic Micro-endoscopy for Detection of Bacteria in Early Stages of Infection. 
(December 2010) 
Nooman Sadat Mufti, B.Tech, Aligarh Muslim University, India;  
M.S., National University of Singapore-MIT Alliance, Singapore                           
Chair of Advisory Committee: Dr. Kristen Carlson Maitland 
 
 Mycobacterium tuberculosis, the bacterium that causes tuberculosis, has an 
incubation period ranging from a few months to several years following infection via 
inhalation into the lungs. Whole body fluorescence scanners are used to image and 
monitor the growth of fluorescent protein expressing strains of M. tuberculosis in the 
lungs of animal models. Accurate quantitative analysis of bacterial growth during the 
early stages of infection inside lungs remains elusive, due to tissue absorption and 
scattering of photons emitted by the low numbers of bacteria deep in tissue. 
Fiber optic micro-endoscopy is uniquely suited to provide a novel solution to this 
problem by delivering light excitation directly to and collecting fluorescence from the 
infection site located in the lungs of an animal model, thereby enabling detection of 
fluorescent bacteria during the early stages of infection. In this thesis, I present a contact 
probe fiber bundle fluorescence micro-endoscope with a range of LED based excitation 
wavelengths, 4 µm resolution, a 750 µm field of view, and a 1 mm outer diameter. This 
system has detected tdTomato and GFP expressing Bacillus Calmette-Guérin (BCG) 
 iv 
bacteria in vitro. Additionally, images of bacterial regions of infection obtained in mice 
subcutaneously infected with tdTomato expressing bacteria at concentrations ranging 
from 106 to 101 Colony Forming Units (CFU) and intra-tracheally infected mice at 106 
CFU demonstrate the micro-endoscope’s capability to detect and resolve regions of 
bacterial infection in vivo. By relaying the bacterial fluorescence image from the 
infection site to an external detector, we are able to increase the sensitivity to early 
stages of infection. 
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This thesis follows the style of the Journal of Biomedical Optics. 
 
1. INTRODUCTION 
 
Bacterial infections such as tuberculosis (TB) affect a large segment of the 
world’s population; the Centers for Disease Control (CDC) estimates approximately 
one-third of the world’s population is currently infected with TB. The disease has an 
incubation period that varies from a few weeks to years. TB is difficult to diagnose at an 
early stage and when it is detected following the onset of symptoms, it requires a 
cocktail of antibiotics in a strict regimen to completely cure a patient. Research into the 
study of the early detection and growth of bacterial infections such as tuberculosis is 
hence imperative [1].  
A variety of clinical techniques exist for the detection of bacterial infections such 
as tuberculosis. These include the Monteux skin test, saliva tests, and X-ray diagnosis 
[2]. These detection techniques are plagued with either low specificity or the ability to 
only detect late stage infections. Moreover, more advanced molecular biology 
techniques such as polymerase chain reaction (PCR) and the enzyme linked immuno-
sorbent assay (ELISA) [3-6] can provide highly accurate bacterial detection and 
quantification capabilities, but not in real time or in vivo. 
Optical imaging and detection utilizes light to interrogate a sample and detects 
either the reflectance or fluorescence from various endogenous or exogenous molecules                                
present, thereby providing a means of real-time and in vivo detection and imaging of 
biological samples. Researchers have developed optical biosensors that can detect in 
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various ex vivo samples [7-9]. Moreover, whole animal fluorescence imaging systems, 
have been developed which are able to image and quantify fluorescent bacterial 
infections from entire animals. These systems are being used for non-invasive in vivo 
pathogenesis studies of bacterial infections [10-14]. However, due to the depth of the 
infectious tissue, such as lung tissue in the case of tuberculosis, tissue absorption and 
scattering of photons emitted by the low numbers of bacteria present precludes the 
possibility of using these systems for early stage quantification of bacterial infections.  
Micro-endoscopes that utilize fiber-optic elements to relay real-time reflectance or 
florescence signals from tissue and organs in vivo are in common use in the healthcare 
sector. They are also currently being developed and evaluated as tools to assist in 
guiding biopsies for the diagnosis of pre-cancer [15-16] and for in vivo pre-clinical brain 
imaging applications [17]. Such a fiber based fluorescence imaging system is uniquely 
suited for the detection and imaging of small regions of bacterial infection inside live 
animals. It can serve as a valuable tool to study the early stage in vivo dynamics of 
bacterial infection, especially when used in concert with whole body imaging systems.   
This thesis highlights the significance of bacterial infections, such as TB and 
TB’s currently understood mechanism of infection and pathogenesis. It delves into 
current technologies that are being researched for bacterial detection and imaging, with 
their merits and limitations. The fluorescence fiber-optic micro-endoscope that we have 
developed, based on a similar system [16], is described. The system characterization 
along with its ability to resolve cellular and tissue level features is established via images 
taken using common fluorescence dyes and dye-stained biological samples. Its utility in 
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imaging bacterial infections in vitro and ex vivo is then described in depth. Finally, 
recommendations for a system design to further improve the scope for the study of the 
physiological spread of tuberculosis and other bacterial agents in live animal models are 
presented.    
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2. BACKGROUND AND SIGNFICANCE 
 
2.1 Tuberculosis 
Tuberculosis (TB) is the leading cause of death in the world due to bacterial 
infection. It usually affects the lungs but can spread to various parts of the body. 
Roughly 1.8 billion people, close to one-third of the world’s population, are infected 
with tuberculosis, and 9 million new cases are reported each year. Close to 2 million 
people worldwide die annually from tuberculosis. HIV is the leading predisposing factor 
for tuberculosis infection and 10 % of all HIV infected people harbor the disease. 
Tuberculosis is also the leading cause of death for HIV infected people [1].  
The active disease is characterized by a chronic cough that is accompanied with 
blood filled sputum, fever and weight loss. The disease spreads when someone with 
active TB coughs, sneezes or sings, thereby releasing the aerosolized form of the 
bacteria into the air that can be inhaled by people nearby.  The bacterium has an 
incubation period that can range from a few months to a few years following the time of 
infection via inhalation into the lungs, making it difficult for the disease to be detected 
early on in the infection [1-2]. 
Mycobacterium tuberculosis (MTB), the bacterium responsible for tuberculosis is 
rod shaped, 2-4 µm in length, and 0.2-0.5 µm in width as can be seen from the scanning 
electron micrograph (SEM) image (Figure 1, [2]). The disease is spread by droplet nuclei 
1-5 µm in diameter released during expectoration from a patient with pulmonary or 
laryngeal tuberculosis. Most of these bacilli get lodged in the nose and throat while some 
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of them are taken up and get lodged in the alveoli of the bronchi. Alveolar macrophages 
non-specifically uptake these bacilli, but since they are not activated, they are not able to 
kill the bacteria.  
 
Figure 1: Scanning electron micrograph image of Mycobacterium tuberculosis (Centers for Disease 
Control) [2]. 
 
One to three weeks post-infection, MTB multiplies without restriction inside the 
inactive macrophages, which then burst, spewing out their bacterial load. Other 
macrophages then get attracted and extravasate to phagocytose these bacilli, but due to 
their inactivation, are not able to eliminate the MTB.  
During stage 3 of the infection, T-cell lymphocyte activation of macrophages 
enables them to kill the bacteria and control the infection via cell mediated immunity. 
This tuberculin-positive stage can be detected via the Monteux skin test. Tubercle (lump) 
formation then takes place when the bacteria are enclosed in a hardened mass. The 
center of the tubercle attains a caseate or cheesy consistency which prevents MTB 
growth due to its low pH and anoxic environment. The MTB can however persist in 
these tubercles for very long periods.  
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During stage 4 of the infection, various inactivated macrophages surrounding the 
tubercles are co-opted by MTB to replicate. This enables the tubercle to grow and invade 
neighboring bronchi and spread to other parts of the lung, a pulmonary spread of the 
disease. The growing tubercle may even reach arteries or blood vessels and enable  
hematogenous spread of the bacteria, an extra-pulmonary spread of the disease. This can 
result in the formation of secondary lesions mostly in the genitourinary system, bones, 
joints, lymph nodes and peritoneum. The lesions can be either exudative, in which the 
bacteria can multiply without restriction in a ‘soft’ tubercle, or they can be 
granulomatous, in which the host’s hypersensitivity results in the formation of a hard 
tubercle that can effectively restrict bacterial growth.  
In stage 5 of the infection, the caseous centers of the tubercles liquefy to produce 
a very conducive medium enabling rapid MTB extracellular growth. This causes the 
nearby bronchi to become necrotic and results in cavity formation, allowing the MTB to 
spread by spilling into it. Only a small percentage of MTB infections cause disease. 
Typically when the primary lesions heal by fibrosis and calcification, they form a Ghon's 
complex, a calcified focus of infection and an associated lymph node, which is readily 
visible in a chest X-ray. They may rarely contain viable bacteria and can be a source of 
the re-activation of the disease later in life. Some metastatic calcified foci containing low 
numbers of viable MTB, known as Simon foci are typically the source of disease re-
activation [2, 18-20]. 
Green fluorescent protein (GFP) complimentary-DNA (cDNA) carrying shuttle 
plasmid vector have been constructed with transcription fusion with promoters of 
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interest and introduced via electroporation into M. tuberculosis and bovis Bacillus 
Calmette-Guérin (BCG) to create transformed fluorescent bacteria [21]. Exposure to 
antibiotics kills off any bacteria that have not been transformed. Such transfected GFP 
expressing bacteria have been used to study pathogenesis of living tissue [10] and are 
even being used as novel fluorescent biosensors based on bacterial response to global 
class of environmental effectors, nutrients or toxins [22].  
2.2 Detection of bacteria 
Various devices have been made for the rapid detection of bacteria in biological 
samples such as blood, saliva, food, and the environment. Taniguchi et al. [7] have 
developed a fiber optic immuno-sensor with a Cyanine-5 (Cy5) labeled polyclonal 
antibody as the detection element immobilized on a polystyrene optical fiber (Figures 2 
A and B). 
 
 
Figure 2: A) Fluorescent immune-assay using an optical fiber [7]; B) process of bacterial immuno-
sensing [7]. 
A 
B 
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Evanescent light from the illuminated fiber excites the Cy5 molecules and the 
fluorescence is collected via a photodiode. The device has been used to detect                                                                                                                                     
Escherichia coli and Listeria monocytogenes in samples. Rapid bacterial identification 
has been performed via the study of the auto-fluorescence spectra of different bacterial 
species like Escherichia coli, Enterococcus faecalis, and Staphylococcus aureus by 
employing excitation light ranging from 330 to 510 nm and employing principal 
component analysis to the detected fluorescence spectra [9]. Other groups are studying 
the activity of bacteria like Streptococcus mutans (the agent responsible for dental 
caries) in bodily fluids like saliva using the exponential decay of the evanescent wave at 
the fiber core-dye encapsulating gel interface [8]. These techniques are very useful as 
portable biosensors for on-site monitoring and detection of bacteria but cannot be used 
for the in vivo detection and imaging of bacterial progression in real time.  
2.3 Pathogenesis studies 
Whole body fluorescence scanners, such as the Caliper Life Sciences In-Vivo 
Imaging System (IVIS Spectrum), have been employed for in vivo preclinical imaging 
applications, including the study of disease progression and gene expression by 
employing co-expression of fluorescent markers. These systems are extensively used for 
the non-invasive detection and growth monitoring of tumors and the effects of 
chemotherapy on tumor size [23-24]. Similarly, for the detection and imaging of 
bacteria, genetically transfected strains of various bacteria such as GFP expressing 
Mycobacterium smegmatis and bovis have been developed [21]. Colonization dynamics 
of C. rodentium and E. coli  [12]  have been studied using whole body imaging at 
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detection limits down to 103 CFU for gut localized bacteria. Entire bacterial biofilms 
have also been detected through macroscopic imaging using the IVIS [11].  
Real-time, in vivo monitoring of bacterial infection occurring at chronic 
subcutaneous and intra-muscular prosthetic implant sites using bioluminescent 
Staphylococcal aureus bacteria prior to and following treatment with antibiotics is also 
being investigated (Figure 3) [14].  
 
Figure 3: Macroscopic images of bioluminescent S. aureus, A) subcutaneously infected;  
B) intra-muscularly infected [14]. 
 
Macroscopic imaging detection limits determined through the studies were 105 
CFU for subcutaneous infection (Figure 3 A) and 106 CFU (Figure 3 B) for intra-
muscular infection. Long term pneumococcal infections in the lungs of living mice have 
been conducted using bioluminescent Streptococcus pneumoniae transformed with a 
gram-positive lux transposon [13]. Kong et al. have employed optical imaging using the 
IVIS Spectrum to study the extrapulmonary spread of tuberculosis after an initial 
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intranasal infection in mice [10]. They have determined that the in vitro detection limit 
for tdTomato expressing bacteria has a ten-fold improvement as compared to enhanced 
GFP (EGFP). On using the higher quantum yield tdTomato expressing bacteria, they 
also determined via subcutaneous infection imaging tests that this system can image and 
quantify mycobacteria at dosage levels greater than 105 CFU. Owing to the highly 
scattering nature of the lungs, to study pulmonary infections, intranasal dosage levels 
greater than 105 CFU are typically employed to study pulmonary infections. However, 
intranasal dosage levels greater than 104 CFU result in extra-pulmonary spread from the 
lungs with non-physiological growth kinetics. Detection limits for various types of 
bacterial infection are summarized in Table 1. Until now, accurate quantitative analysis 
of bacterial growth during the early stages of infection in the lungs and at low bacterial 
concentrations has not been possible, primarily due to scattering and tissue absorption of 
photons emitted from the low numbers of fluorescent bacteria present deep in the tissue. 
A need arises for a system that can image and quantify pulmonary bacterial infection at 
inoculums below 105 CFU during the first few days following infection to model early 
stage and low bacterial load infection. The system must also be able to image below 104 
CFU for the study of the physiological spread of the infection into extra-pulmonary 
areas. To my knowledge, no fiber based micro-endoscopes have been used previously 
for studying bacterial infection.  
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Table 1: Bacterial detection limits using whole animal imaging scanners. 
Reference Bacteria Inoculation 
dose 
Luminescence 
modality 
Detection limit Location of 
bacteria/infection 
[12] Citrobacter 
rodentium 
109 CFU (oral) Bioluminescent 103 CFU In vivo (gut) 
[14] S. aureus 106-108 CFU 
(subcutaneous 
catheter 
implant,  thigh 
injection) 
Bioluminescent 105 CFU 
(subcutaneous), 
106 CFU 
(muscle) 
In vivo 
(subcutaneous, 
muscle tissue) 
[10] M.bovis 
BCG 
101- 107  CFU Fluorescence 
(EGFP)  
103 CFU  In vitro 
[10] M. bovis 
BCG 
101- 107 CFU Fluorescence 
(tdTomato) 
102 CFU  In vitro  
[10] M. bovis 
BCG 
104-107CFU 
(subcutaneous) 
Fluorescence 
(EGFP) 
107 CFU In vivo 
(subcutaneous) 
[10] M. bovis 
BCG 
104-107CFU 
(subcutaneous) 
Fluorescence 
(tdTomato) 
105 CFU In vivo 
(subcutaneous) 
 
2.4 Fiber bundle micro-endoscopes 
2.4.1 Optical fluorescence microscopy 
Fluorescence microscopy is a widely used technique in biology. Excitation light 
in an epi-illumination or Ploem illumination configuration is first reflected off a dichroic 
mirror and focused by an objective lens onto a fluorescent sample. The fluorescence 
from the sample, which occurs at wavelengths longer than the excitation, is then 
collected by the same objective and focused onto a detector using a lens (Figure 4, [25]). 
Since most of the excitation light passes through the sample, only reflected excitation 
light and emitted light is collected by the objective. In combination with an emission 
filter placed before the detector, this serves to provide a very high signal-to-noise ratio.  
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Figure 4: Epi-fluorescence microscope setup (Molecular Cell Biology, [25]). 
 
The theoretical maximum resolution of a fluorescence microscope is the Abbe or 
diffraction limited focused spot size, equal to one-half of the wavelength of the light 
used (0.26 µm for a 520 nm GFP emission). This is also the shortest distance between 
the maxima of the point spread functions or Airy disks formed from 2 individual points 
of light from the sample that can be distinguished by the optical system. The resolution 
of the optical system is defined by              , where   is the wavelength of light 
and NA is the numerical aperture of the objective and condenser lenses used [26]. 
2.4.2 Micro-endoscopy 
Micro-endoscopes employing a scanning mechanism at the distal end of a single-
mode fiber have been developed having a lateral resolution of 0.8 µm and confocal 
sectioning ability due to the fiber acting as a confocal pin-hole [27]. Fiber bundle micro-
endoscopes involve the use of a coherent fiber bundle, comprising thousands of 
individual fibers, with the proximal end placed after the objective lens to collect the 
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focused excitation light. The distal end of the fiber, which is placed in contact with the 
fluorescent sample, relays the fluorescent signal back onto the same objective lens. The 
advantage of using a fiber bundle in place of a single-mode fiber is that the need for a 
distal end scanning mechanism is eliminated and the use of wide field illumination and 
fluorescence collection via the same bundle obviates the need for a scanning mechanism 
altogether. The core to core spacing of the fiber elements determines the limit of the 
lateral resolution of the system and the active imaging bundle area determines the field-
of-view of the system. For instance, for a typical Sumitomo IGN-08/30, a 0.9 mm outer 
diameter fiber bundle comprising approximately 30000 fibers, with a core size of 2.2 µm 
and a core-to-core spacing of 4 µm [28], the lateral resolution determined is 
approximately 4 µm with a 750 µm field-of-view.  
A fiber optic plate microscope comprising a contact probe fiber bundle coupled 
with a conventional fluorescence microscope was first reported for in vivo imaging of 
brain structure and physiological activity (Figure 5 A and B) [17, 29]. Fiber bundle optic 
micro-endoscopes have since been used for diverse applications including the in vivo 
imaging of tumors and for pre-cancer detection in epithelial cells and tissue in the oral 
mucosa [16].  
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Figure 5: A) Schematic of the fiber-optic plate microscope system. a, xenon lamp; b and h, filters; c, bundle 
optical fiber; d, dichroic mirror e, objective lens; f, fiber-optic plate;  i, ICCD  camera; 1, color monitor;   
B) Fiber optic plate schematic: The fiber-optic plate is 50 mm in length and 1 mm in diameter. It is comprised 
of thousands of optical fibers, 3 μm in diameter with a core-to-core spacing of 3 μm, which determines the 
lateral resolution of the system [17, 29]. 
 
Muldoon et al. have built a wide field Light Emitting Diode (LED) illumination 
based, 1 mm diameter fiber bundle micro-endoscope capable of sub-cellular resolution 
imaging (4 µm resolution with 750 µm field of view) for pre-cancer detection in the oral 
mucosa [16]. Fiber optic confocal fluorescence micro-endoscopes have also been 
developed that employ a scanning mechanism at the proximal fiber bundle end and 
utilize each fiber element as a pin-hole to remove out-of-focus light, thereby enabling 
optical sectioning [15, 30]. They have been used for pre-cancer detection using 
morphology discrimination by imaging epithelial cells from cervical tissue, fluorescence 
lifetime imaging for biochemical analysis [31], as well as the morphological and 
functional imaging of in vivo microvasculature [32]. Confocal fluorescence micro-
endoscopes have also been modified for spectroscopy and multispectral imaging of 
varied dye stained samples [33-34]. These systems have the advantage of high resolution 
by optical sectioning but at the expense of loss of signal with removal of scattered light. 
Wide-field contact-probe fluorescence micro-endoscopes have a much less complex, 
non-scanning system design and collect scattered fluorescence, which improves 
A B 
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sensitivity, but at the cost of resolution. Although major advances in optical fiber based 
high resolution in vivo imaging systems have been achieved in the field of early cancer 
detection, to my knowledge, fiber optic micro-endoscopy has not yet been applied to in 
vivo imaging and detection of bacteria.   
Tuberculosis is a global health issue and knowledge of its early growth kinetics 
and pathogenesis which is essential to effectively combat it, is limited. Wide field optical 
imaging techniques are being used to study pathogenesis but do not provide an accurate 
analysis of bacterial growth at early stages of infection and at low bacterial 
concentrations. Moreover, low resolution, low sensitivity fiber based systems have been 
used for bacterial detection, but not for imaging. Fiber bundle micro-endoscopes have 
the potential to provide a unique imaging platform for studying early stages of bacterial 
infection and at low concentrations. 
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3. SYSTEM DESIGN 
 
3.1 Micro-endoscope setup 
A contact probe based fiber optic micro-endoscope, capable of providing 
efficient excitation and collection of fluorescence light from regions of bacterial 
infection, was designed, constructed and optimized. The resulting setup was capable of 
imaging and resolving bacterial colonies in vitro and regions of infection in excised 
subcutaneous and lung tissue.  
3.1.1 Fluorescence mode 
Figure 6 illustrates the layout of the fluorescence micro-endoscope, the basic 
design of which is modeled after the system described in the background section [16]. 
Excitation light from the LED source is collimated by a lens and filtered by an excitation 
filter, if necessary, to obtain a narrow wavelength band. The excitation light is then 
reflected by a dichroic mirror and focused by an objective lens onto a fiber bundle. The 
fiber bundle transmits the excitation light to its distal tip, which is placed in contact with 
the sample. The resulting fluorescence light from the sample is collected by the same 
fiber bundle, filtered by emission filters, and imaged onto a scientific grade CCD camera 
(QImaging Exi Blue, 1.45 Mpixels, 6.45 µm x 6.45 µm pixel size).  
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Figure 6: Schematic of fluorescence micro-endoscope for preclinical imaging. 
 
The tube lens (150 mm focal length, Thorlabs achromatic doublet) in concert 
with an 18.2 mm focal length, 10x Leica objective lens, provides a magnification of 8.2x 
(determined by the ratio of the focal length of the tube lens to the focal length of the 
objective) to focus the entire 750 µm active area of the fiber bundle onto the 2/3 inch 
(diagonal) CCD camera. The system has a range of LED based excitation wavelengths to 
excite various fluorophores with corresponding dichroic, excitation and emission filters 
procured from Chroma technologies mounted on filter wheels (Table 2). The resolution 
of the system, determined by the fiber core-to-core spacing specification of 4 µm and the 
field-of-view, determined by the active imaging area of the 1mm outer diameter fiber 
bundle is 750 µm. Figure 7 illustrates the top and side views of the constructed system. 
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Figure 7: A) Top-view of the fluorescence micro-endoscope system; B) side-view of system;                                                    
C) inset image of the distal (imaging) end of probe. 
 
B 
C 
A 
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Table 2: LED and filter wavelengths for various fluorophores. 
LED 
excitation 
wavelength 
(nm) 
Dichroic 
mirror cut-on 
wavelength 
(nm) 
Band pass 
excitation filter 
center 
wavelength (nm)  
(if applicable) 
Emission 
filter cut on 
wavelength 
(nm) 
Fluorescent proteins and dyes 
470  495 470 
40 nm BW 
505 tdTomato, mKeima, EGFP, 
Acridine Orange, Fluorescein 
590 600 NA 610 mCherry, mKate, mKeima  
680 690 NA 700 Cy5.5 
790 800 NA 810 IrDye 
 
3.1.2 Reflectance mode 
The system can also be configured in reflectance mode by replacing the dichroic 
mirror with a beam splitter and swapping the excitation and emission filters with crossed 
polarizers. The excitation light incident on the fiber bundle is polarized. Back reflection 
from the proximal bundle surface is removed by the crossed polarizer. Light that travels 
to the distal tip of the bundle experiences scattering and loss of polarization in the tissue, 
allowing signal to pass through the crossed polarizer and onto the CCD.   
3.2 Selection of optical elements 
Efficient coupling of excitation light from the LED into the fiber bundle is 
critical to increase illumination of the sample and subsequent fluorescence signal for 
detection. Furthermore, a higher excitation power at the distal tip enables greater 
penetration of the light into the tissue. This will be essential for imaging at a specific 
depth in the tissue through the addition of an objective lens on the fiber tip, which is 
planned as a future modification of the system. 
 
 
b 
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3.2.1 Selection of LEDs 
LEDs were chosen with the minimum possible divergence angle at the highest 
available output power so as to maximize the optical coupling into the fiber bundle. 
LEDs from Roithner LaserTechnik with a minimum available full-viewing (divergence) 
angle of 30 degrees were chosen at various wavelengths corresponding to the peak 
excitation wavelengths of fluorophores enumerated previously in Table 2. 
3.2.2 Optical coupling lens system for fiber bundle 
Standard achromatic doublet and aspheric objective lenses, Fresnel lenses and 
reflective and refractive collimators were used to improve collimation of the wide beam 
output of the LEDs into a narrow beam focused onto the fiber bundle proximal face to 
improve light coupling. 
A 19 mm achromatic doublet was used to collimate the LED light. The 
magnification of the collimated light size as it passes through the focusing lens is 
determined by m=                                 (where F is the focal length). The 
second lens was chosen such that the focal length was either the same or smaller than the 
collimating lens, so that a spot size of the same dimensions as the LED die or smaller 
was focused onto the fiber bundle. This helps to maximize light focused within the 
bundle’s active area. Hence, an achromatic doublet of the same focal length, Fresnel 
lenses and aspheric lenses were explored to obtain the best coupling into the fiber. 
Aspheric lenses maximize the numerical aperture keeping the lens diameter a minimum. 
Minimization of the spot size on the fiber by choosing a smaller focal length and optimal 
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matching of the NA of the focusing lens (tube lens) to the fiber NA of 0.33 should 
improve optical coupling. The results are summarized in Table 3. 
 
Table 3: Focusing lens combinations for optimization of optical coupling into fiber. 
 
Focusing lens, focal length 
(mm) 
Numerical aperture 
of focusing lens 
Power coupled into fiber w/o 
excitation filter (in mW) 
Achromatic doublet, 19 mm  0.33 0.6 
Infinity corrected objective 
lens (Leica, L-10X), 18.2 mm 
0.25 0.9  
Fresnel Lens, 15 mm 0.85 1.3 
Fresnel Lens, 10 mm  0.63 1.49 
Aspheric lens, 11 mm 0.25 1.4 
Aspheric lens, 8 mm 0.5 1.61 
Aspheric lens, 3.1 mm 0.68 0.65 
Aspheric lens, 6.24 mm 0.4 1.585 
Aspheric lens, 15.4 mm 0.16 0.77 
Aspheric lens, 4.5 mm 0.55 1.2 
 
Based on the results, the highest optical coupling obtained is with the 8mm focal 
length aspheric lens, with a coupling of 1.61 mW without and 1.3 mW with a band-pass 
excitation filter (1.34 % and 1.1 %, respectively, with the LED output at 120 mW). This 
is followed by the 6.24 mm focal length aspheric lens with a coupling of 1.585 mW of 
light (1.32 %). The infinity corrected achromatic doublet (Leica L-10X) was chosen to 
minimize aberrations and since it had an NA of 0.25 which was very close to the 
averaged NA of 0.33 for fibers in the entire bundle. This combination provided a power 
output of 0.9 mW. Further improvements in the coupling will require a delicate removal 
of the dome lens of the LEDs and the use of smaller focal length collimating lenses so 
that a narrower beam of light can be focused onto the bundle while keeping the beam 
NA smaller than the fiber bundle NA. This will help to maximize incoming light that is 
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internally reflected. Laser light sources can also be employed in place of the LEDs since 
they have very low beam divergence which can enable the focused beam NA at the fiber 
tip to be minimized.  
3.3 Fiber bundle selection 
A Sumitomo IGN-08/30 fiber bundle was used in the in vitro and ex vivo 
subcutaneous experiments. A fiber bundle comprising 30,000 individual fibers, with a 
fiber core- to-core separation specification of 4 µm (the spacing can vary between 3 to 4 
µm owing to tolerances in the fiber bundle manufacturing process) was chosen. The 
selection was performed such that the fibers had the smallest available core-to-core 
spacing, with the minimum available diameter for multi-mode fibers (~ 3 µm) and had 
the highest available NA (0.35) for efficient optical coupling. For future in vivo endo-
tracheal imaging, an appropriate bundle size is essential so that it may fit into 
conventional endoscopic guides and catheters that are typically employed in animal 
studies. An endo-tracheal catheter of a specific gauge size can accommodate needle sizes 
smaller than its inner diameter for intra-tracheal infection of mice. Likewise, fiber 
bundles smaller than this size can be inserted into these catheters and manipulated freely 
inside the animal. Bundles of overall diameters in the range of 0.6-0.7 mm can 
efficiently fit in a 22 gauge catheter, which is typically used in the endo-tracheal 
infection of mice. Hence, an IGN-05/10 fiber-bundle, comprising 10,000 elements, 4 µm 
fiber-to-fiber spacing in a 660 µm bundle diameter was ordered for future work.  
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4. METHODS 
 
Following the design of the system, the characterization of its performance in 
imaging simple fluorescent samples is essential before moving on to the imaging of 
fluorescent bacteria, which is the main aim of the study. This is useful in determining the 
resolution and detection limits of the system. It is also useful in judging whether the 
system parameters such as excitation power, background and excitation light removal 
are optimized to obtain quality images. The detection limits of the imaging system at low 
fluorescence levels similar to those expected from in vivo fluorescent bacteria were 
assessed with this information.  
Ex vivo imaging of subcutaneously and intra-tracheally infected mice help to 
determine the in vivo detection capability and system optimization for subsequent in vivo 
imaging of lung tissue. Bacillus Calmette-Guérin (BCG) bacteria, an attenuated form of 
the live bovine tuberculosis bacillus, Mycobacterium bovis and used as a vaccine for 
Mycobacterium tuberculosis, was used in all the experiments. BCG was chosen for the 
study for safety considerations owing to their non-virulence to humans. The work 
performed here is approved by the Texas A&M Institutional Animal Care and Use 
Committee, AUP no. 2008-278. 
4.1 System characterization using a resolution target and fluorescent dye stained 
samples 
The system was first set in reflectance mode for imaging the reflectance 
resolution target and then to fluorescence mode for imaging the dye stained samples.  
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4.1.1 Resolution target imaging 
A 1951 USAF resolution target (Edmund optics, NT38-256) was imaged by 
contacting the fiber bundle onto the reflectance target and finding the smallest 
discernible line pairs as well as the lines pairs that have distinctly separable pairs. This 
information, which is available in lines per mm is then inverted and halved to determine 
the minimum line width that can be resolved by the system.  
4.1.2 Fluorescent sample imaging 
Common fluorescent dyes such as acridine orange and fluorescein were prepared 
in standard concentrations (1 mg/mL), and imaging was performed by directly placing 
the probe into the liquid media. The fluorescent light output was then quantified by 
analyzing the images taken by the camera via the ImageJ software. Concentrations were 
subsequently diluted to test the detection limit of the camera.  
1 mg/mL concentrations of the DNA intercalating dye, acridine orange was used 
to stain the nuclei of tissue samples of hamster cheek pouches acquired through tissue 
sharing (Dr. Brian Applegate’s cancer study at Texas A&M University) to assess the 
cellular and tissue resolution capabilities of the system. Staining was performed by 
soaking the samples in the dye for approximately 10 minutes. This was followed by  
washing with phosphate buffer solution to clear off excess un-reacted dye. 
4.2 In vitro imaging of fluorescent bacterial colonies 
Bacteria expressing various proteins such as green fluorescent protein (GFP), 
tdTomato, mKeima and mCherry were grown in colonies on agar as well as in 
suspension in culture medium. The probe was placed in contact with the in vitro sample 
  
25 
and the fluorescent signal from the bacteria was collected by the fiber bundle and 
imaged onto the CCD. This information was then used to characterize the sensitivity for 
bacteria expressing different fluorescent proteins in order to select the optimal 
fluorescent protein for subsequent ex vivo experiments on excised tissue from infected 
animals. Although individual bacteria were not expected to be resolved by the imaging 
system, ability to resolve bacterial colonies may indicate sufficient capability to image 
regions of bacterial infection ex vivo as well as in vivo.  
4.3 Ex vivo imaging of mice subcutaneously infected with fluorescent bacteria 
Subcutaneous injection of a bolus of bacteria provides a localized population of a 
known concentration in an accessible location for a simple test of the imaging system’s 
capability to detect and image regions of bacterial infection. Six mice were divided into 
two groups that were anesthetized and injected with 50 µL of three different 
concentrations of tdTomato expressing bacteria subcutaneously. Each animal was 
injected with a negative control sample. The first group was injected with 106, 105 and 
104 colony forming units (CFU) while the second group was injected with 103, 102 and 
101 CFU. Imaging was performed one day following infection, using the appropriate 
excitation and emission filters for tdTomato.  
The mice were euthanized and excoriated in the infection zone and imaging was 
performed from the underside of the skin (Figure 8 A). For each imaging site, in three 
regions where a definite signal was obtained, a biopsy was carried out with a 1 mm 
punch biopsy needle (Miltex sterile disposal with plunger, Figure 8 B). Three negative 
control sites per concentration were also imaged and biopsied.  
  
26 
 
Figure 8: A) ex vivo imaging of excoriated subcutaneous tissue; B) biopsy samples being taken 
from excoriated subcutaneous tissue; circles depict injection sites. 
 
These biopsy samples were then transferred to a growth medium and 
subsequently incubated for a period of three weeks for CFU count measurements. 
Separate biopsies of confirmed infection sites were also taken for a histo-pathological 
investigation. The fiber-bundle fluorescence signal was quantified for the three regions 
of different concentration and the control to validate the experiment. This data will then 
be compared with the biopsy CFU count to analyze the correlation between the two.  
4.4 Ex vivo imaging of excised lung tissue from intra-tracheally infected mice 
Imaging of excised lung tissue allows determination of the sensitivity of the 
system to image bacteria within lung tissue and characterization of the probable 
locations of bacteria within the respiratory system following intra-tracheal infection. In 
addition to improved access to the lung tissue in comparison to in vivo lung imaging, ex 
vivo imaging circumvents size restrictions imposed on the probe during in vivo imaging. 
A catheter was inserted into the trachea of the six previously anesthetized mice (common 
to the subcutaneous experiments). A bolus containing 106 CFU fluorescent bacteria each 
for five mice, and 106 CFU of a non-fluorescent control in the sixth mouse was then 
A B 
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administered. A day was allowed post injection of bacteria into the respiratory system of 
the mice, to permit bacteria to reach deeper regions of the lungs. The mice were then 
euthanized and their lung tissues were excised. Imaging was performed at various sites 
(trachea and bronchi) to identify the regions with the maximum fluorescence signal. This 
will aid in anticipation of regions of early infection for guidance of probe placement 
during future in vivo lung imaging. 
 
  
  
28 
5. RESULTS 
 
5.1 System characterization 
5.1.1 Imaging of Air Force resolution target 
A 1951 USAF resolution target was imaged using the system to confirm the 
theoretical resolution and field-of-view values determined by the fiber bundle 
specifications. As shown in the reflectance image of the resolution target (Figure 9 A), 
group 6, element 4 is clearly visible and the last group that is barely discernible is group 
7, element 2 (blow-up shown in Figure 9 B). 
 
 
Figure 9: A) Reflectance image of Air-force resolution target; B) blow-up of group 7, element 2. 
 
5.5 µm 
3.5 µm 
A B 50 µm 
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According to the Edmund Optics specification charts [35], Group 6, element 4 
has 90.5 lines pairs per mm corresponding to 5.5 µm/line width. Group 7, element 2 has 
144 lines pairs per mm, corresponding to a 3.5 µm resolution. Therefore, the system can 
clearly distinguish features down to 5.5 µm and the point beyond which there is 
difficulty in distinguishing between different lines corresponds to resolution limit of 3.5 
µm. This value agrees with the limit established earlier corresponding to the fiber core-
to-core spacing that has a manufacturing specification of 4 µm but can vary between 3 to 
4 µm. 
5.1.2 Demonstration of cellular and tissue level resolution  
The cellular and tissue level resolution of the system was determined via the 
imaging of 15 µm fluorescent microspheres and nucleic acid-fluorescence stained 
hamster cheek epithelial cells.  
15 µm Dye-Trak fluorescent microspheres were injected into a PBS solution to 
create a fluorescent microsphere suspension. This was then imaged by placing the fiber-
bundle inside the PBS solution. As can be seen from the image in Figure 10, those 
microspheres which are in contact with the probe are clearly visible as a pixilated image 
(corresponding to the superposition of the bundle structure on the microsphere image). 
Microspheres that are not physically in contact with the bundle are visible as blurred 
spots with lower intensity.  
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Figure 10: A) Dye-Trak yellow 15 µm fluorescent microspheres; B) blow-up of image region 
showing individual microspheres. 
 
The tissue of the hamster cheek pouch stained with fluorescent dye was imaged. 
The nuclei stained by the acridine orange are clearly visible as seen from the encircled 
example from the image in Figure 11. The system gave well resolved images of hamster 
cheek pouch cells (typically 10 µm in diameter). This suggests that the system is capable 
of resolving typical cellular and tissue level features. 
50 µm 
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Figure 11: Hamster cheek epithelial cells stained with acridine orange. 
 
5.2 In vitro imaging of GFP-actin expressing cells 
GFP-actin expressing osteoblast cells (provided by Dr. Roland Kaunas, Texas 
A&M University) grown in vitro, were imaged on a petri-dish as shown in Figure 12, at 
an exposure of 780 msec and a gain setting of 7. The images show well resolved 
osteoblast cell structure that demonstrates the cellular resolution capability of the 
system. In addition, these results demonstrate promise for future dual-channel imaging 
of GFP expressing cells infected by tdTomato expressing bacteria. 
 
50 µm 
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Figure 12 : A) GFP actin expressing cells grown in vitro; B) in vitro negative control. 
 
5.3 In vitro imaging of bacterial samples 
  To assess the sensitivity of the system to image bacteria expressing different 
proteins, fluorescent strains of bacteria were imaged in vitro. Images of tdTomato and 
GFP expressing bacterial colonies grown on agar were successfully obtained in vitro as 
shown in Figures 13 A and B. Based on the signal and resolution, these images indicate 
that both GFP and tdTomato expressing bacterial colonies can be detected and well 
resolved in vitro, in comparison to the negative control (non-fluorescent BCG with 
vector backbone, Figure 13 C). We hence expect GFP and tdTomato expressing regions 
of bacterial infection to be detectable in vivo. The tdTomato protein has a higher 
quantum yield than enhanced GFP (0.69 as compared to 0.6 for the EGFP, [36]) and a 
brightness (product of quantum yield and extinction coefficient) that is 2.8 times higher 
than EGFP [37]. Being a red-shifted protein, tdTomato emits in the 580 to 700 nm range, 
where there is a steep drop in the light absorption owing to hemoglobin in tissue [38]. 
Moreover, tissue auto-fluorescence is reduced at higher wavelengths. Therefore 
tdTomato expressing bacteria were chosen for our subsequent experiments.  
50 µm 50 µm A B 
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Figure 13: A) GFP expressing bacterial colonies grown on agar; B) tdTomato expressing bacterial 
colonies grown on agar; C) negative control on agar (non-fluorescent BCG bacteria with vector 
backbone) 
 
5.4 Ex vivo imaging of subcutaneously infected mice tissue 
Subcutaneously injected tdTomato expressing bacteria at concentrations varying 
from 106 to 101 CFU were then imaged ex vivo as shown in Figures 14, 15 and 16 (all 
images presented were contrast enhanced by 72 % and brightness enhanced by 50 %). 
The corresponding macroscopic image taken with the IVIS Spectrum system is shown in 
Figure 14F. Sites inoculated with 106 CFU (Figures 14 A and B) and 105 CFU (Figures 
14 C and D), clearly show well resolved bacterial infection foci (regions encircled green) 
in comparison to the 106 CFU of non-fluorescent negative control bacteria (Figure 14 E), 
which displays only background auto-fluorescence. This is also corroborated with the 
macroscopic IVIS system image. 
 
 
A B 
50 µm 50 µm 50 µm 
C 
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control 
Figure 14: tdTomato expressing bacteria injected subcutaneously at various 
concentrations: A) and B) 106 CFU; C) and D) 105 CFU; E) 106 CFU of non-fluorescent 
bacteria (negative control); F) macroscopic IVIS image of subcutaneously infected tissue. 
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Bacterial concentrations down to 104 CFU (Figures 15 A and B) are clearly 
detected in comparison to the negative controls (Figures 15 E and F) and corroborated 
with the IVIS images, which did not give any signal for inocula below 103 CFU. For the 
lower bacterial concentrations, 103 CFU (Figure 15 C and D), 102 CFU (Figures 16 A 
and B) and 101 CFU (Figures 16 C and D), there appears to be ambiguity in determining, 
whether the fluorescence signal is from bacteria that are attached or associated with 
fibrous auto-fluorescent structures or are from topological features in the structures 
themselves. For instance, in Figure 15 D, bacteria (encircled green, lower left), appear to 
be attached to the fibrous structure; while in Figure 15 C, it isn’t clear whether the bright 
spots (encircled blue) associated with the fibers are bacteria or part of the surrounding 
anatomical features. The inoculation dose from 101 CFU to 106 CFU appears to correlate 
with the size of the bacterial infection foci. 
There seems to be site to site variability within the same bacterial concentration 
as is visible from the comparison of Figures 14 A and B for an inoculum of 106 CFU and 
14 C and D for an inoculum of 105 CFU.  Background auto-fluorescence between 
samples also varies, as can be seen from the auto-fluorescent fibrous structures seen in 
the negative control images in Figures 15 E and F. This variability can also be seen 
between the images of the 101 CFU bacterial concentration and negative control, the 101 
CFU sample having lower auto-fluorescence than the negative control (Figures 16 C and 
F respectively).  
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Figure 15: tdTomato expressing bacteria injected subcutaneously at various concentrations: A) and 
B) 104 CFU; C) and D) 103 CFU; E) and F) 106 CFU of non-fluorescent bacteria (negative 
controls). 
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Figure 16: tdTomato expressing bacteria injected subcutaneously at various concentrations: A) and 
B) 102 CFU; C) and D) 101 CFU; E) and F) 106 CFU of non-fluorescent bacteria (negative 
controls). 
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5.5 Ex vivo imaging of lung tissue infected intra-tracheally with 10
6
 CFU of bacteria 
 
Following the success of the subcutaneous imaging, the lungs of the mice were 
excised and imaged ex vivo. Figures 17 A and B display regions of fluorescent bacterial 
infection in the lung tissue as compared to mice inoculated intra-tracheally with non-
fluorescent bacteria as seen in Figure 17 C.  The corresponding macroscopic images 
obtained with the IVIS are shown in Figure 17 D. The 106 CFU fluorescent bacteria 
inoculum images in Figures 17 A and B clearly show detectable regions of bacterial 
infection (encircled green) as compared to the negative controls in Figure 17 C. The 
fluorescence images again corroborate those obtained from the IVIS. Variability in the 
size of the regions of infection in figures 17 A and B is again visible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50 µm 
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Figure 17: tdTomato expressing bacteria injected intra-tracheally into the lungs of mice at 106 CFU (A) and (B); 
(C) 106 CFU of non-fluorescent bacteria injected intra-tracheally into the lungs (negative control); (D) macroscopic 
IVIS image of 106 CFU intra-tracheal inoculum of fluorescent bacteria. 
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6. DISCUSSION 
 
6.1 Analysis of images 
The characterization studies show that features down to 4 µm are clearly visible, 
as seen in the resolution target image (Figure 9). Moreover, the well resolved images of 
the 15 µm microspheres (Figure 10), as well as the 10 µm hamster cheek cells (Figure 
11), demonstrate the cellular and tissue level resolution of the system. Human cells in 
comparison are 1-10 µm in size, with the nuclei being typically less than 5 µm. 
These results are corroborated by in vitro imaging of GFP actin expressing cells 
(Figures 12 A and B) and bacterial colonies expressing fluorescent proteins (Figures 13 
A and B). These data show that both tdTomato and GFP expressing BCG bacteria can be 
detected and resolved.  This further indicates that the system is capable of detecting 
bacteria in ex vivo and in vivo samples. No structural information could be obtained from 
bacterial colonies expressing mCherry and mKeima, perhaps because the system’s filters 
were not optimized for those wavelengths. The tdTomato protein has a higher quantum 
yield (0.69 as compared to less than 0.6 for EGFP [36]), and a brightness (product of 
quantum yield and extinction coefficient) that is 2.8 times that of EGFP [37] and the 
highest for the red-shifted proteins. tdTomato emits in the 580 to 700 nm range, where 
there is a steep drop in the light absorption owing to hemoglobin in tissue [38]. 
Furthermore, tdTomato expressing cells have been shown to provide higher detection 
sensitivity for in vivo optical imaging applications as compared to EGFP [10]. It was 
therefore selected as the fluorescent protein of choice for the rest of the experiments.  
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Although imaging bacteria in the lung is the ultimate goal, imaging bacteria of 
concentrations from 106 to 101 CFU subcutaneously injected in the skin of mice provides 
well controlled conditions and ease of accessibility for characterizing sensitivity in 
tissue. Since the imaging probe can, at present, only image areas that are in contact with 
bundle-tip, owing to limited optical penetration depth in tissue, the mice were excoriated 
to expose the underside of the skin for direct imaging of the infection site. Comparing 
the imaging results in Figures 14 A and B (106 CFU) as well as 14 C and D (105 CFU) 
with the negative control in Figure 14 E, we find clearly detectable regions of bacterial 
infection. This also corroborates with the regions of infection indicated by macroscopic 
imaging IVIS Spectrum (Figure 14 F).  Detectable regions of bacterial infection can also 
be seen at concentrations down to 104 as is visible in Figures 15 A and B. There is 
ambiguity in the detection of regions of infection for the lower inoculums, 103 CFU 
(Figure 15 C and D), 102 CFU (Figures 16 A and B) and 101 CFU (Figures 16 C and D) 
in comparison to the negative controls (Figure 15 E and F and Figures 16 E and F). The 
size of the infection foci within the field of view seem to correlate with the inoculum. 
However, as can be seen from a comparison of images Figures 14 A and B as 
well as Figures 15 A and B, there is variability in the size of the regions of infection 
between different imaging sites with the same inoculum. It is possible that there is 
heterogeneity in the distribution of bacteria after injection into the tissue owing to the 
dynamics of the inoculum fluid flow in the subcutaneous tissue. Since the probe’s field-
of-view is much smaller than the region of inoculation and infection, we may not 
necessarily be imaging the same concentration as the inoculum. This variation between 
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imaging sites may also be explained by an ‘infection’ diffusion gradient that is visible in 
the macroscopic IVIS system image (Figure 14 F) as a region of decreasing bacterial 
concentration that spreads outward from the point of injection. This phenomenon could 
be due to the dynamics of the inoculum fluid flow in the subcutaneous tissue as well as 
cellular uptake rates during phagocytosis and how that is influenced by variation in 
inoculum concentration. It is possible that when imaging two different sites close 
together, zones of different levels of infection may be touched upon and hence a 
different fluorescence signal will result. These theories may also apply to images 
obtained from two different concentrations displaying regions of infection having the 
same size as can be seen from Figures 15 B (104 CFU) as compared to 16 C (101 CFU).  
The variability in the auto-fluorescence background signal as displayed in 
Figures 15 E and F (negative controls) as well as between Figures 16 C and F (101 CFU 
and negative control, respectively) could be due to the presence and variation of fiber 
like structures which contribute to the auto-fluorescence. Bacteria also appear to 
aggregate or associate with some of these auto-fluorescent fiber structures as seen in 
Figure 15 D. The ambiguity associated with some of the images appearing to be either 
regions of bacterial infection, or anatomical features within the tissue structure, should 
become clear following a CFU count measurement and after analysis of histopathology 
information from the site biopsies. 
Images of ex vivo lung tissue, Figures 17 A and B, indicate that definite regions 
of fluorescent bacterial infection can be detected in lung tissue as compared to excised 
lung tissue infected with 106 CFU of non-fluorescent bacteria (Figure 17 C). These 
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images correlate well with the corresponding regions shown in the macroscopic images 
taken with the IVIS system (Figure 17 D). Bifurcation points in the trachea were seen to 
typically have a larger number of bacteria. Fluorescence from deeper regions of the 
lungs was also detected, which could be attributed to the respiration of the mouse as well 
as normal physiological processes such as drainage of bacteria via the lymphatic system. 
These results show promise for this device to be used for in vivo imaging of 
regions of bacterial infection inside the lungs of animals by delivering the fiber probe to 
the site of infection using a catheter. This approach can be used to assist whole body 
imaging systems in identifying and imaging regions of infection at a higher resolution so 
as to perform time-studies of physiological processes such as phagocytosis. Initially, in 
vivo imaging of higher inoculation doses may be guided by whole body fluorescence 
imaging scanners. Eventually regions of infection at concentrations lower than the 
detection limit for macroscopic imaging systems may also be accurately imaged.  
6.2 Image quantification and evaluation of the limit of detection  
6.2.1 Image quantification 
To assess the variation in the fluorescence intensity with increasing inoculum 
dose and variation within the fluorescence intensities of each individual inoculum, the 
fluorescence intensity of each image obtained was averaged over all the pixels. The 
scatter plot of the average fluorescence intensity from the negative control and each 
inoculum dose was plotted against the inoculum dose on a log scale as shown in Figure 
18. The mean fluorescence intensity at each inoculum versus the inoculum dose was 
plotted as shown in Figure 19.    
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Figure 18: Scatter-plot of average fluorescence intensity over the probe’s field-of-view vs. 
subcutaneous fluorescent bacterial inoculum.  
 
 
 
Figure 19: Average fluorescence intensity over the probe’s field of view vs. subcutaneous 
fluorescent bacterial inoculum. 
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As can be seen from the scatter plot in Figure 18, an increasing trend is seen in 
the average fluorescence intensity with increasing inoculum levels. Additionally, a bi-
modal distribution is seen for the average fluorescence at each inoculum, with a group of 
low values (encircled blue) and high values (encircled green). This can be explained 
from the fact that when the probe is placed in contact with a subcutaneous infection 
zone, due to the heterogeneity in the local distribution of the bacteria within the field of 
view of the probe, very low as well as higher, more representative levels of bacteria for 
each inoculum are sampled. This can be seen for every inoculum dose as groups of low 
and high fluorescence intensity measurements.    
 An increasing trend is seen in the average fluorescence intensity with increasing 
inoculum dose till 105CFU beyond which there seems to be saturation in the bacterial 
load that a tissue sample within the field-of-view can hold.   
 A correlation between the average fluorescence intensity and the subcutaneous 
inoculum dose was then performed as seen in Figure 19. The logarithmic regression fit 
to the data (with an R2 value of 0.57), again displays an increasing trend, with the mean 
fluorescence of all inocula above 102 CFU being above the negative-control’s mean 
level. The presence of a good correlation would be advantageous in determining a 
calibration curve for the system so as to enable rapid quantification of regions of 
fluorescent bacterial infection.  
6.2.2 Statistical evaluation of the limit of detection using Student’s t-test 
 To determine the detection limit of the system, a statistical analysis of the 
average fluorescence vs. inoculum data was performed using Statgraphics Centurion®. 
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A Box-and-Whisker plot (Figure 20) for the entire data set was performed to evaluate 
the variation in the fluorescence intensity with increasing inoculum dose and within the 
same inoculum. As was noted earlier, the mean levels (red square) of the fluorescence 
intensities at each fluorescent bacterial inoculum are higher than that for the negative 
control. There is an overlap in the intensities for the 101 CFU and 102 CFU inocula with 
the negative control data.  
 To accurately compare the means of each of the fluorescence intensities with the 
negative control, and to determine which inoculum dose has a statistically significant 
difference in its mean fluorescence as compared to that of the negative control, a 
Student’s t-test was performed for each of the negative control-fluorescent inoculum 
dose pairs. A descriptive example for the comparison of the fluorescence intensities of 
the negative-control vs. 102 CFU is provided.  
 
Figure 20: A Box-and-Whisker plot of the average fluorescence intensity vs. subcutaneous 
inoculum dose. 
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The 95.0% confidence interval for the mean fluorescence intensity from the 
negative control was determined to be 1693.33 ± 82.9665 (ranging from 1610.37 to 
1776.3). The 95.0% confidence interval for the mean fluorescence intensity obtained 
from the 102 CFU inoculum was determined to be 1998.33 ± 401.891 (ranging from 
1596.44 to 2400.22) and that for the difference between these two assuming equal 
variances was -305.0 ± 287.093   (ranging from -592.093 to -17.9068). Since this range 
does not contain the value 0, it indicates that there is a statistically significant difference 
between the two means at the 95 % confidence interval.  
The null hypothesis states that the mean for the fluorescence intensities obtained 
for the negative control and each inoculum dose compared to it are equal. The alternate 
hypothesis states that they are not equal. Assuming equal variances, we obtain a p-value 
of 0.039 for the t-test between the negative control and 102 CFU data. Since the p-value 
is lower than 0.05, we can hence reject the null-hypothesis in favor of the alternate 
hypothesis. There is hence a statistically significant difference between the mean 
fluorescence obtained from the negative control samples in comparison to that obtained 
from the 102 CFU inoculum. The p-values for the negative control and each of the higher 
inoculum doses are also lower than 0.05 (with the exception of the 104 inoculum data 
with a close p-value of 0.054). Performing the t-test for the negative control and the 
lower inoculum of 101 CFU, we get a p-value of 0.39. Since this is greater than 0.05, we 
cannot reject the null hypothesis and hence there is not a statistically significant 
difference between the two samples. The p-values for the comparison between the 
negative-control and the various inocula are summarized in Table 4. Since the lowest 
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inoculum dose that has a p-value lower than 0.05 when compared to the negative control 
is 102 CFU, the detection limit for the system is determined to be 102 CFU.  
From a statistical point of view, the system is be able to detect bacteria down to 
102 CFU. Based on the earlier mentioned ambiguity in the images taken for the 
inoculums lower than 104 CFU, the presence of bacteria in lower inocula will have to be 
verified via CFU measurements. 
 
Table 4: P-values for a Student’s t-test comparison of the mean fluorescence                
intensity obtained from 10
6 
CFU of negative control with various subcutaneous 
inocula of fluorescent bacteria. 
 
Fluorescent bacteria 
inoculum (CFU) 
P-value for mean fluorescence 
comparison of inoculum with 
10
6
 CFU of negative control 
101  0.395 
102 0.039 
103 0.029 
104 0.054 
105 0.002 
106 0.015 
 
 
 
 
  
b 
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7. CONCLUSIONS AND FUTURE WORK 
 
A fluorescent micro-endoscope with a resolution of 4 µm and a field of view of 
750 µm diameter was developed. System characterization using a resolution target 
confirmed that features of 5.5 µm were clearly visible and a resolution limit of 3.5 µm 
was possible. Moreover, in vitro imaging of 15 µm fluorescent microspheres, dye 
stained hamster cheek cells and GFP-actin expressing osteoblast cells demonstrated the 
cellular and tissue level resolution of the system. 
In vitro imaging of tdTomato and GFP expressing bacteria showed that the 
system could detect and resolve bacteria and ex vivo imaging of mice subcutaneously 
infected with tdTomato expressing cells confirmed similar imaging capabilities at the 
tissue level. Well resolved regions of bacterial infection were visible at the higher 
subcutaneous bacterial inoculum concentrations (106 and 105 CFU) as compared to the 
negative controls that display only background auto-fluorescence. In addition, bacteria at 
concentrations down to 104 CFU could also be detected and distinguished from 
background auto-fluorescence. These bacterial infection site images agree with the 
macroscopic images taken with the IVIS system and display signal at concentrations 
lower than 103 CFU where the IVIS did not register bacteria.  
As explained earlier, the site to site variation in the size of the region of infection 
for the same inoculum may be attributed to heterogeneity in the bacterial concentration 
and the smaller size of the probe’s field of view as compared to the region of infection. 
This observation may also be due to interplay between the concentration gradient 
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centered at the injection site and bacterial drainage via the lymphatic system. This is 
further seen in the bi-modal distribution visible in the scatter plot of the average 
fluorescence intensity vs. inoculum in Figure 18, where both low and high fluorescence 
intensities are seen for each inoculum. 
Based on the statistical analysis of the quantified images, the system’s limit of 
detection was determined to be 102 CFU. It is hence possible that bacteria were also 
detected at inocula down to 102 CFU. Ambiguity in bacterial detection that might be 
confused with anatomical features present in the auto-fluorescence for inocula lower 
than 104 CFU will have to be cleared up by examining the histo-pathology images and 
CFU determination from the biopsies.  
The fluorescence signal from the bacteria in the images seems to correlate with 
the inoculum dose, and this is confirmed with the increasing trend seen in the scatter 
plots for the average fluorescence vs. inoculum dose (Figure 18) and the regression fit 
for the mean fluorescence vs. inoculum dose (Figure 19). The auto-fluorescence 
background is not constant and it remains to be seen if it can cause any issues with a 
correlation between the fluorescence signal and the CFU counts.  
An important step forward will be to optimize the excitation wavelengths using 
suitable band-pass filters and dichroic mirrors so that the fluorescence emission from 
tdTomato is maximized and tissue auto-fluorescence is minimized. Suitable emission 
filters employing narrow bands in place of long pass filters will also be explored to 
reduce the auto-fluorescence background and improve the signal-to-noise (SNR) ratio.  
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To improve the quantitative aspects of the system in imaging regions of bacterial 
infection using the system, it would be beneficial to have a mechanism to either 
minimize or remove the auto-fluorescence. This can be done by performing spectral un-
mixing of the imaging data to remove wavelengths corresponding to the emission 
characteristics of the tissue auto-fluorescence. A system modification that can also 
enable this could be a replacement of the fixed emission filters with liquid crystal 
tunable filters (LCTF) which change their pass-bands on the application of electrical 
current. By analyzing the emission characteristics of the auto-fluorescence structures at 
various wavelengths for each pixel of the image and comparing it with the emission 
characteristics of the fluorophore used (tdTomato), the auto-fluorescence signal can be 
removed via linear subtraction from the image. Spectral-unmixing can also be useful in 
separating out the fluorescence signal from GFP cells and tdTomato cells in order to 
visualize/quantify them separately without having to add another imaging channel to the 
existing system. Another option can be to replace the existing high resolution camera 
with a hyper-spectral or multi-spectral camera (in which the key component is again the 
LCTF), which are generally bundled with propriety spectral un-mixing software. Auto-
fluorescence can also be minimized by switching to a bioluminescence strategy. By 
using bacteria or cells that are bioluminescent instead of fluorescent, the SNR can be 
maximized by reducing auto-fluorescence caused by the excitation light. 
Another key improvement that we aim to implement is to modify the system to 
enable 2-channel imaging of GFP and tdTomato. This will allow dual imaging of GFP 
expressing cells in mice being invaded by tdTomato expressing bacteria as well as 
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investigation of the types of cells that phagocytose bacteria with their corresponding 
dynamics. This can go a long way in visualizing and explaining the physiological spread 
of bacteria at low inoculum concentrations from the lungs into pulmonary and extra-
pulmonary regions, the details of which are not presently well understood.   
 
 
 
 
 
  
  
53 
REFERENCES 
 
1. "Centers for Disease Control, Tuberculosis (tb) Statistics,"   
http://www.cdc.gov/tb/statistics/default.htm, July 1, 2010). 
2. K. Todar. "Todar's Online Textbook of Bacteriology,"   
www.textbookofbacteriology.net/tuberculosis.html (July 21, 2010). 
3. J. Kim, D. Byun, M.G. Mauk, and H.H. Bau, "A disposable, self-contained pcr 
chip," Lab on a Chip 9(4), 606-612 (2009). 
4. H. Wiesinger-Mayr, K. Vierlinger, R. Pichler, A. Kriegner, A.M. Hirschl, E. 
Presterl, L. Bodrossy, and C. Noehammer, "Identification of human pathogens 
isolated from blood using microarray hybridisation and signal pattern 
recognition," BMC Microbiology 7, 78-94 (2007). 
5. Y. Yamamoto, "Pcr in diagnosis of infection: Detection of bacteria in 
cerebrospinal fluids," Clinical and Diagnostic Laboratory Immunology 9(3), 508-
514 (2002). 
6. P. Apfalter, F. Blasi, J. Boman, C.A. Gaydos, M. Kundi, M. Maass, A. 
Makristathis, A. Meijer, R. Nadrchal, K. Persson, M.L. Rotter, C.Y.W. Tong, G. 
Stanek, and A.M. Hirschl, "Multicenter comparison trial of DNA extraction 
methods and pcr assays for detection of chlamydia pneumoniae in 
endarterectomy specimens," Journal of Clinical Microbiology 39(2), 519-524 
(2001). 
  
54 
7. M. Taniguchi, E. Akai, T. Koshida, K. Hibi, H. Kudo, K. Otsuka, H. Saito, K. 
Yano, H. Endo, and K. Mitsubayashi, "A fiber optic immunosensor for rapid 
bacteria determination," 3rd Kuala Lumpur International Conference on 
Biomedical Engineering 2006 15, 308-311 (2007). 
8. M.S. John, A. Kishen, L.C. Sing, and A. Asundi, "Determination of bacterial 
activity by use of an evanescent-wave fiber-optic sensor," Applied Optics 41(34), 
7334-7338 (2002). 
9. H.E. Giana, L. Silveira, R.A. Zangaro, and M.T.T. Pacheco, "Rapid identification 
of bacterial species by fluorescence spectroscopy and classification through 
principal components analysis," Journal of Fluorescence 13(6), 489-493 (2003). 
10. Y. Kong, S. Subbian, S.L.G. Cirillo, and J.D. Cirillo, "Application of optical 
imaging to study of extrapulmonary spread by tuberculosis," Tuberculosis 89, 
S15-S17 (2009). 
11. J.L. Kadurugamuwa and K.P. Francis, "Bioluminescent imaging of bacterial 
biofilm infections in vivo," Methods Mol Biol 431, 225-239 (2008). 
12. S. Wiles, K.M. Pickard, K. Peng, T.T. MacDonald, and G. Frankel, "In vivo 
bioluminescence imaging of the murine pathogen citrobacter rodentium," 
Infection and Immunology 74(9), 5391-5396 (2006). 
13. K.P. Francis, J. Yu, C. Bellinger-Kawahara, D. Joh, M.J. Hawkinson, G. Xiao, 
T.F. Purchio, M.G. Caparon, M. Lipsitch, and P.R. Contag, "Visualizing 
pneumococcal infections in the lungs of live mice using bioluminescent 
  
55 
streptococcus pneumoniae transformed with a novel gram-positive lux 
transposon," Infection and Immunity 69(5), 3350-3358 (2001). 
14. N.A. Kuklin, G.D. Pancari, T.W. Tobery, L. Cope, J. Jackson, C. Gill, K. 
Overbye, K.P. Francis, J. Yu, D. Montgomery, A.S. Anderson, W. McClements, 
and K.U. Jansen, "Real-time monitoring of bacterial infection in vivo: 
Development of bioluminescent staphylococcal foreign-body and deep-thigh-
wound mouse infection models," Antimicrobial Agents and Chemotherapy 47(9), 
2740-2748 (2003). 
15. C. Liang, M.R. Descour, K.B. Sung, and R. Richards-Kortum, "Fiber confocal 
reflectance microscope (fcrm) for in-vivo imaging," Optics Express 9(13), 821-
830 (2001). 
16. T.J. Muldoon, M.C. Pierce, D.L. Nida, M.D. Williams, A. Gillenwater, and R. 
Richards-Kortum, "Subcellular-resolution molecular imaging within living tissue 
by fiber microendoscopy," Optics Express 15(25), 16413-16423 (2007). 
17. M. Hirano, Y. Yamashita, and A. Miyakawa, "In vivo visualization of 
hippocampal cells and dynamics of ca2+ concentration during anoxia: Feasibility 
of a fiber optic plate microscope system for in vivo experiments," Brain Research 
732(1-2), 61-68 (1996). 
18. I. Smith, "Mycobacterium tuberculosis pathogenesis and molecular determinants 
of virulence," Clinical Microbiology Reviews 16(3), 463-496 (2003). 
19. T.R. Frieden, T.R. Sterling, S.S. Munsiff, C.J. Watt, and C. Dye, "Tuberculosis," 
Lancet 362(9387), 887-899 (2003). 
  
56 
20. S.K. Sharma and A. Mohan, "Extrapulmonary tuberculosis," Indian Journal of 
Medical Research 120(4), 316-353 (2004). 
21. S. Dhandayuthapani, L.E. Via, C.A. Thomas, P.M. Horowitz, D. Deretic, and V. 
Deretic, "Green fluorescent protein as a marker for gene-expression and cell 
biology of mycobacterial interactions with macrophages," Molecular 
Microbiology 17(5), 901-912 (1995). 
22. E. Sagi, N. Hever, R. Rosen, A.J. Bartolome, J.R. Premkumar, R. Ulber, O. Lev, 
T. Scheper, and S. Belkin, "Fluorescence and bioluminescence reporter functions 
in genetically modified bacterial sensor strains," Sensors and Actuators B-
Chemical 90(1-3), 2-8 (2003). 
23. M. Vooijs, J. Jonkers, S. Lyons, and A. Berns, "Noninvasive imaging of 
spontaneous retinoblastoma pathway-dependent tumors in mice," Cancer 
Research 62(6), 1862-1867 (2002). 
24. M. Yang, E. Baranov, P. Jiang, F.X. Sun, X.M. Li, L.N. Li, S. Hasegawa, M. 
Bouvet, M. Al-Tuwaijri, T. Chishima, H. Shimada, A.R. Moossa, S. Penman, and 
R.M. Hoffman, "Whole-body optical imaging of green fluorescent protein-
expressing tumors and metastases," Proceedings of the National Academy of 
Sciences of the United States of America 97(3), 1206-1211 (2000). 
25. H.F. Lodish, Molecular Cell Biology  6th ed (W.H. Freeman, 2008). 
26. G. Cox, Optical Imaging Techniques in Cell Biology  (CRC/Taylor & Francis, 
2007). 
  
57 
27. K.C. Maitland, H.J. Shin, H. Ra, D. Lee, O. Solgaard, and R. Richards-Kortum, 
"Single fiber confocal microscope with a two-axis gimbaled mems scanner for 
cellular imaging," Optics Express 14(19), 8604-8612 (2006). 
28. "Sumitomo electric, USA,"   
http://www.sumitomoelectricusa.com/scripts/products/ofig/image.cfm (July 21, 
2010). 
29. M. Hirano, Y. Yamashita, and A. Miyakawa, "Development of a fiber-optic plate 
microscope system and visualization of cells stained with fluorescent dyes 
masahiko," Analytical Sciences 9(3), 375-380 (1993). 
30. A.F. Gmitro and D. Aziz, "Confocal microscopy through a fiber-optic imaging 
bundle," Optics Letters 18(8), 565-567 (1993). 
31. G.T. Kennedy, H.B. Manning, D.S. Elson, M.A.A. Neil, G.W. Stamp, B. 
Viellerobe, F. Lacombe, C. Dunsby, and P.M.W. French, "A fluorescence 
lifetime imaging scanning confocal endomicroscope," Journal of Biophotonics 
3(1-2), 103-107 (2010). 
32. E. Laemmel, M. Genet, G. Le Goualher, A. Perchant, J.F. Le Gargasson, and E. 
Vicaut, "Fibered confocal fluorescence microscopy (cell-vizio (tm)) facilitates 
extended imaging in the field of microcirculation:- a comparison with intravital 
microscopy," Journal of Vascular Research 41(5), 400-411 (2004). 
33. F. Jean, G. Bourg-Heckly, and B. Viellerobe, "Fibered confocal spectroscopy and 
multicolor imaging system for in vivo fluorescence analysis," Optics Express 
15(7), 4008-4017 (2007). 
  
58 
34. A.R. Rouse and A.F. Gmitro, "Multispectral imaging with a confocal 
microendoscope," Optics Letters 25(23), 1708-1710 (2000). 
35. Edmund Optics. "1951 usaf glass slide resolution targets,"   
http://www.edmundoptics.com/onlinecatalog/displayproduct.cfm?productid=179
0 (July 21, 2010). 
36. "Tdtomato-our brightest red fluroescent protein,"   
http://www.clontech.com/images/ctq/OCT08UPD/CR8X2830_CTQOct08_tdTom
ato_US.pdf (July 21, 2010). 
37. N.C. Shaner, P.A. Steinbach, and R.Y. Tsien, "A guide to choosing fluorescent 
proteins," Nature Methods 2(12), 905-909 (2005). 
38. N.C. Deliolanis, R. Kasmieh, T. Wurdinger, B.A. Tannous, K. Shah, and V. 
Ntziachristos, "Performance of the red-shifted fluorescent proteins in deep-tissue 
molecular imaging applications," Journal of Biomedical Optics 13(4), 044008-
044016 (2008). 
 
 
 
 
 
 
 
 
  
59 
VITA 
 
Nooman Sadat Mufti received his Bachelor of Technology degree in chemical 
engineering from the Z.H. College of Engineering and Technology, Aligarh Muslim 
University, India, in 2004. Following this, he entered the Molecular Engineering of 
Biological and Chemical Systems program at the National University of Singapore-
Massachusetts Institute of Technology Alliance, Singapore and received a Master of 
Science degree in 2006. He then took a Process Engineer position at Wacker Chemicals, 
Siltronic Singapore Pte. Ltd. until 2008.  
He joined the Biomedical engineering department at Texas A&M University in 
2008 under the supervision of Dr. Kristen Carlson Maitland and received his M.S. in 
biomedical engineering in December 2010. His research interests include optical 
imaging and detection using techniques such as micro-endoscopy for disease prognosis 
and progression studies and in the areas of neural imaging for decoding the information 
associated with neural ensemble measurements.  
 
 
 
 
 
 Mailing address: 337 Zachary Engineering Center  
 
    3120 TAMU 
     
    College Station, TX, 77843-3120 
 
    c/o Kristen Maitland 
 
 Email:   nauman.sm@gmail.com 
